Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.0033 | 0.9 |
mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.007 | 0.9 |
mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.0028 | 0.9 |
mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |